COMMUNIQUÉS West-GlobeNewswire

Sanara MedTech Inc. Reports Unaudited Preliminary Results for the Fourth Quarter and Full Year 2024
21/01/2025
Fourth Quarter Net Revenue Expected to Increase 45% to 48% Year-Over-Year; Full Year Net Revenue Expected to Increase 32% to 33% Year-Over-Year FORT WORTH, TX, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc . [...]
AdCare Rhode Island Welcomes Community to Free Educational Event on the Use of Medications to Treat Addiction
21/01/2025
NORTH KINGSTOWN, R.I., Jan. 21, 2025 (GLOBE NEWSWIRE) -- In response to Rhode Island’s ongoing addiction and overdose crisis, AdCare Rhode Island , a leading provider of substance use and co-occurring disorder treatment [...]
Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
21/01/2025
WATERTOWN, Mass., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ: IRON) (Disc), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments [...]
Oculis Publishes Notification of Major Changes in Voting Rights
21/01/2025
ZUG, Switzerland, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Attached is a Notification of Major Changes in Voting Rights. Attachment Notification of Major Changes in Voting Rights - Íslandsbanki (21 Jan 2025)
BioAdaptives Announces FINRA Approval of a Dividend for Common Stock Shareholders
21/01/2025
LAS VEGAS, Jan. 21, 2025 (GLOBE NEWSWIRE) -- via IBN – BioAdaptives Inc. (OTC: BDPT), a forward-thinking innovator in health and wellness solutions, is pleased to announce that FINRA has approved a dividend to its [...]
Rising from the Ashes: Ivy En Rose MedSpa Reopens in San Francisco, Exemplifying Strength and Community Spirit
21/01/2025
Beloved MedSpa Overcomes Devastating Fire and Challenges to Continue Serving the Bay Area SAN FRANCISCO, Jan. 21, 2025 (GLOBE NEWSWIRE) -- In a remarkable display of resilience and determination, Ivy En Rose MedSpa is [...]
UPDATE - NeurAxis Announces New Medical Policy Coverage with a Prominent Insurer for Over Five Million Lives Across Multiple States
21/01/2025
CARMEL, Ind., Jan. 21, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and [...]
LifeLabs Named Canada’s Most Trusted Health Diagnostic Service Provider for Third Consecutive Year by BrandSpark Most Trusted Awards
21/01/2025
Toronto, Ontario, Jan. 21, 2025 (GLOBE NEWSWIRE) -- LifeLabs is proud to announce that it has been named Canada’s Most Trusted Health Diagnostic Service Provider for the third year in a row by the 2025 BrandSpark Most [...]
Intuitive Announces Plans to Establish Direct Presence in Italy, Spain, Portugal
21/01/2025
Acquisition of distributor business expands Intuitive’s investment and footprint in Europe SUNNYVALE, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive [...]
Argentum 47, Inc. Announces Acquisition of Marelius Biopharma Group, Divestiture of Argentum Data Solutions, and Leadership Transition
21/01/2025
LAS VEGAS, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Argentum 47, Inc. (OTC PINK: ARGQ) (“Argentum” or the “Company”) today announced a series of transformative developments, including the acquisition of Marelius Biopharma [...]
Pharming Group to convene Extraordinary General Meeting of Shareholders
21/01/2025
Leiden, the Netherlands, January 21, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces it will hold an Extraordinary General Meeting of Shareholders (EGM) on [...]
EssilorLuxottica: Déclaration de transactions sur actions propres
21/01/2025
Déclaration de transactions sur actions propres Paris, France (21 janvier 2025, 18h00) – Conformément à l’autorisation octroyée par l’Assemblée Générale du 30 avril 2024, EssilorLuxottica déclare que du 14 janvier 2025 [...]
Scilex Holding Company Announces that It Regains Nasdaq Compliance Under Listing Rule 5250(c)(1)
21/01/2025
PALO ALTO, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid [...]
ACTG Launches Second HIV Cure Clinical Trial in Africa
21/01/2025
ACACIA Study Is Evaluating Two Long-Acting Broadly Neutralizing Antibodies Given at HIV Treatment Initiation LOS ANGELES, Jan. 21, 2025 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other [...]
H.H.C. Group Offers Complimentary Claim Review to Jump-Start Health Plan Payor Savings in 2025
21/01/2025
ROCKVILLE, MD, Jan. 21, 2025 (GLOBE NEWSWIRE) -- H.H.C. Group (H.H.C.), the leader in reducing healthcare costs by providing high-quality cost containment using claim negotiation, repricing and independent review [...]
RS BioTherapeutics Announces Positive Anti-Inflammatory and Anti-Fibrotic Effects of Lead Compound in Human Lung Tissue
21/01/2025
First-in-class, steroid-free compound reduced inflammatory and fibrotic biomarkers in human lung tissue furthering support as a new advancement in the treatment of deadly lung diseases CUMBERLAND, Md., Jan. 21, 2025 ( [...]
Scilex Holding Company Announces Extension of the Maturity Date of its Secured Promissory Note Issued to Oramed Pharmaceuticals Inc. to December 31, 2025
21/01/2025
PALO ALTO, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid [...]
Cell BioEngines Announces Establishment of New R&D Facility to Further Advance Its Platform and Pipeline of Innovative Cell Therapies
21/01/2025
Cell BioEngines Joins Center for Engineering and Precision Medicine (CEPM), Expands Relationship with Mount Sinai NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Cell BioEngines, Inc. (“Cell BioEngines” or the “Company”), a [...]
Neoviva est la première clinique suisse de traitement des dépendances à offir une garantie
21/01/2025
LUCERNE, Suisse, 21 janv. 2025 (GLOBE NEWSWIRE) -- Neoviva, un centre de réadaptation de luxe de premier plan, lance le premier et unique programme de garantie en matière de traitement des dépendances en Suisse. Doté d’ [...]

Pages